© 2004 European Society of Cardiology
Hereditary hemochromatosis gene (HFE) mutations C282Y, H63D and S65C in patients with idiopathic dilated cardiomyopathy
a Department of Clinical Chemistry, University of Oulu P.O. Box 5000, Oulu, Finland
b Institute of Medical Technology, University of Tampere and Tampere University Hospital Finland
c Department of Internal Medicine, University of Kuopio Finland
d Department of Internal Medicine, University of Helsinki Finland
e Medical Informatics Group, University of Oulu Oulu, Finland
* Corresponding author. Tel.: +358-50-351-0270; fax: +358-3-215-8597. E-mail address: jokkeha{at}paju.oulu.fi
 |
Abstract |
|---|
Background: Hereditary hemochromatosis (HH), a common autosomal recessive disease, leads to excessive iron accumulation in some organs, including the heart. It is therefore not surprising that cardiomyopathy is one of the most severe complications of HH. The HFE gene defects have been thought to contribute to idiopathic dilated cardiomyopathy (IDCM) in some patients, even though the results of genotype analyses have so far been contradictory. Hence we set out here to evaluate the prevalence and potential role of HFE mutations in patients with IDCM.
Methods: A total of 91 IDCM patients and 102 controls were subjected to HFE mutation analyses, in which C282Y, H63D and S65C mutations were determined for each patient. We also analyzed the impact of the C282Y and H63D mutations on the left ventricular end-diastolic diameter (LVEDD), left ventricular ejection fraction (LVEF) and New York Heart Association (NYHA) functional classes.
Results: The prevalences of heterozygosity for the C282Y, H63D and S65C mutations in the IDCM patients were 13.2%, 22.0% and 2.2%, respectively. LVEDD was significantly higher (P=0.037) in those with the C282Y mutation at the end of the follow-up period than in those with no mutation.
Conclusions: Our data showed no significant deviations in C282Y, H63D and S65C mutation frequencies between the IDCM patients and controls, suggesting that these mutations do not increase the risk of IDCM. Heterozygosity for the C282Y mutation may nevertheless be a modifying factor contributing to LV dilatation and remodeling.
Key Words: Hereditary hemochromatosis • Hereditary hemochromatosis gene • C282Y • H63D • S65C • Idiopathic dilated cardiomyopathy
Received December 8, 2003; Revised January 6, 2004; Accepted March 20, 2004